mhurhangee/patent-ind-claim-en huggingface dataset:
Aluminum alloy, in particular aluminum casting alloy, characterised in that the aluminum alloy contains the following alloying elements: Silicon: 10 wt% to < 13 wt%, Nickel: up to < 0.6 wt%, Copper: 1.5 wt% to < 3.6 wt%, Magnesium: 0.5 wt% to 1.5 wt%, Iron: 0.1 wt% to 0.7 wt%, Manganese: 0.1 to 0.4 wt%, Zirconium: > 0.1 to < 0.3 wt%, Vanadium: > 0.08 to < 0.2 wt%, Titanium: 0.05 to < 0.2 wt%, Phosphorus: 0.0025 to 0.008 wt%, the rest consisting of aluminum and unavoidable impurities.
A method of priming an extracorporeal blood circuit using a blood treatment apparatus comprising a dialysis liquid preparation system having a source of water, a source (B) of bicarbonate concentrate and a source (A) of acid concentrate including sodium chloride, and configured to prepare a dialysis liquid from water, said bicarbonate concentrate and said acid concentrate only, said extracorporeal blood circuit comprises an arterial line section , connectable to a patient, for drawing blood from the patient, a venous line section , connectable to the patient, for returning the blood to the patient, and a blood side compartment or blood chamber of a blood filter , said method encompassing the steps of a first phase: - preparing a priming solution from said source of water and said source (A) of acid concentrate only to obtain an acid/water solution, - connecting said arterial line section to an outlet of the dialysis liquid preparation system of the blood treatment apparatus and, - filling the extracorporeal blood circuit with said priming solution characterized in that - the dialysis liquid preparation system is not having, or is not being connected to, a source that comprises sodium chloride only or exclusively; and in that - bicarbonate from the source (B) of bicarbonate concentrate is absent from said solution. said extracorporeal blood circuit comprises an arterial line section , connectable to a patient, for drawing blood from the patient, a venous line section , connectable to the patient, for returning the blood to the patient, and a blood side compartment or blood chamber of a blood filter , said method encompassing the steps of a first phase: - preparing a priming solution from said source of water and said source (A) of acid concentrate only to obtain an acid/water solution, - connecting said arterial line section to an outlet of the dialysis liquid preparation system of the blood treatment apparatus and, - filling the extracorporeal blood circuit with said priming solution - preparing a priming solution from said source of water and said source (A) of acid concentrate only to obtain an acid/water solution, - connecting said arterial line section to an outlet of the dialysis liquid preparation system of the blood treatment apparatus and, - filling the extracorporeal blood circuit with said priming solution characterized in that - the dialysis liquid preparation system is not having, or is not being connected to, a source that comprises sodium chloride only or exclusively; and in that - bicarbonate from the source (B) of bicarbonate concentrate is absent from said solution. - the dialysis liquid preparation system is not having, or is not being connected to, a source that comprises sodium chloride only or exclusively; and in that - bicarbonate from the source (B) of bicarbonate concentrate is absent from said solution.
A switched capacitor arrangement for tuning a differential circuit comprising: a first capacitor branch , wherein the first capacitor branch comprises: a first node , a second node and a third node ; a first capacitor coupled between the first node and the second node ; a second capacitor coupled between the second node and the third node ; a second capacitor branch , wherein the second capacitor branch comprises: a first node , a second node and a third node ; a third capacitor coupled between the first node and the second node ; a fourth capacitor coupled between the second node and the third node ; and a first switch branch comprising a first switch (S1) coupled between the second nodes of the first and second capacitor branches; and wherein the first switch (S1) has an on state and an off state; the first nodes and the third nodes of the first and second capacitor branches are configured to be connected to respective differential nodes of the differential circuit; and the switched capacitor arrangement is configured to tune the differential circuit by controlling the state of the first switch (S1); characterised in that the first and second capacitor branches have same capacitance, wherein a capacitance ratio of the first capacitor to the second capacitor is 1/(1+x), and a capacitance ratio of the third capacitor to the fourth capacitor is (1+x), where 0<x<1. a first capacitor branch , wherein the first capacitor branch comprises: a first node , a second node and a third node ; a first capacitor coupled between the first node and the second node ; a second capacitor coupled between the second node and the third node ; a first node , a second node and a third node ; a first capacitor coupled between the first node and the second node ; a second capacitor coupled between the second node and the third node ; a second capacitor branch , wherein the second capacitor branch comprises: a first node , a second node and a third node ; a third capacitor coupled between the first node and the second node ; a fourth capacitor coupled between the second node and the third node ; and a first node , a second node and a third node ; a third capacitor coupled between the first node and the second node ; a fourth capacitor coupled between the second node and the third node ; and a first switch branch comprising a first switch (S1) coupled between the second nodes of the first and second capacitor branches; and wherein the first switch (S1) has an on state and an off state; the first nodes and the third nodes of the first and second capacitor branches are configured to be connected to respective differential nodes of the differential circuit; and the switched capacitor arrangement is configured to tune the differential circuit by controlling the state of the first switch (S1); characterised in that the first and second capacitor branches have same capacitance, wherein a capacitance ratio of the first capacitor to the second capacitor is 1/(1+x), and a capacitance ratio of the third capacitor to the fourth capacitor is (1+x), where 0<x<1.
Membrane electrode unit with a seal which is arranged on the edge region of the membrane electrode unit , wherein the seal on the one hand penetrates into the edge region of the membrane electrode unit and on the other hand grips around and fully covers the edge region on both sides outside the membrane electrode unit , and a sealing frame which surrounds the membrane electrode unit and grips around the edge region with the seal on both sides.
A method for mitigating cyber security threats by devices using risk factors, comprising: determining a plurality of risk factors for a device based on a plurality of risk behaviors indicated by network activity and information of the device; determining a risk score for the device based on the plurality of risk factors and a plurality of weights, wherein each of the plurality of weights is applied to one of the plurality of risk factors; and performing at least one mitigation action based on the risk score; the method characterized in that the at least one mitigation action includes monitoring network activity by the device when the risk score is below a threshold, further comprising: updating the risk score based on the monitored network activity; and performing at least one subsequent mitigation action based on the updated risk score. determining a plurality of risk factors for a device based on a plurality of risk behaviors indicated by network activity and information of the device; determining a risk score for the device based on the plurality of risk factors and a plurality of weights, wherein each of the plurality of weights is applied to one of the plurality of risk factors; and performing at least one mitigation action based on the risk score; the method characterized in that the at least one mitigation action includes monitoring network activity by the device when the risk score is below a threshold, further comprising: updating the risk score based on the monitored network activity; and performing at least one subsequent mitigation action based on the updated risk score. updating the risk score based on the monitored network activity; and performing at least one subsequent mitigation action based on the updated risk score.
A compound having the general formula I H ― L(HA) wherein H is a head group selected from wherein A in head group 1 comprises 5 and 6 cyclic aryl and heteroaryl-systems, n is 0 to 6; p is 0 to 6; X and Y are each independently selected from CH 2 , C=O and C=S; Z is selected from the group comprising H, alkyl and with m being 0 to 6, R is selected from the group comprising H, alkoxy, hydroxy, alkyl (preferably C 1 -C 10 alkyl), alkoxyaryl, aryl, halogenyl, nitro, amino, amidyl, cyano, sulfanyl, sulfinyl, sulfonyl, formyl, acetyl, with o being 0 to 6, R' and R" are each independently selected from the group comprising H, alkyl, aryl and substituted aryl; K is selected from the group comprising alkyl residues and with i being 0 to 6; L is a linker comprising a hydroxamic acid ( HA ) and having the formula with q being 0 or 1, or a pharmaceutically acceptable salt thereof. A in head group 1 comprises 5 and 6 cyclic aryl and heteroaryl-systems, n is 0 to 6; p is 0 to 6; X and Y are each independently selected from CH 2 , C=O and C=S; Z is selected from the group comprising H, alkyl and with m being 0 to 6, R is selected from the group comprising H, alkoxy, hydroxy, alkyl (preferably C 1 -C 10 alkyl), alkoxyaryl, aryl, halogenyl, nitro, amino, amidyl, cyano, sulfanyl, sulfinyl, sulfonyl, formyl, acetyl, with o being 0 to 6, R' and R" are each independently selected from the group comprising H, alkyl, aryl and substituted aryl; K is selected from the group comprising alkyl residues and with i being 0 to 6; L is a linker comprising a hydroxamic acid ( HA ) and having the formula with q being 0 or 1,
Method for manufacturing a tyre comprising: - a tread , - an airtight internal layer , - at least one layer of a self-sealing product extending circumferentially radially on the inside of part of the airtight internal layer , during which method a strip or a bead of a self-sealing product is wound through multiple circumferential turns (Nai, Nbj) radially on the inside of the airtight layer of the tyre, which does not have the layer of self-sealing product yet, and at least partially in line with the tread , the winding step being carried out according to a law for winding circumferential turns of the strip or of the bead , characterized in that, during the winding step, at least one parameter of the winding law making it possible to axially vary the thickness of the layer of self-sealing product is varied over at least 50% of the circumferential length of the layer of self-sealing product . - a tread , - an airtight internal layer , - at least one layer of a self-sealing product extending circumferentially radially on the inside of part of the airtight internal layer ,
Method for detecting the extinguishing of a flame on a burner surface of a burner for burning gas, wherein temperature changes of the flame are measured at least with a first temperature sensor and a second temperature sensor , wherein the first temperature sensor and the second temperature sensor are arranged at a different distance from the burner surface , characterised in that an extinguishing of the flame is detected when a deviation in the temperature changes measured with the first temperature sensor and the second temperature sensor reaches a threshold.
A heating mechanism for a biochemical reaction device, comprising: a heat-conducting body , the heat-conducting body comprising: at least one accommodating groove each comprising a chamber and an opening communicating with the chamber ; and a clamping hole , in communication with the opening and for insertion of a reaction tube ; at least one heat-conducting block , movably disposed in the chamber and having one end connected to an elastic element and another opposite end provided with an abutting portion , the elastic element enabling the abutting portion of the heat-conducting block to protrude from the opening and locate in the clamping hole ; and a temperature control element, being connected to the heat-conducting body for heating and regulating a temperature of the heat-conducting block ; characterised in that the abutting portion of the heat-conducting block is spherical. a heat-conducting body , the heat-conducting body comprising: at least one accommodating groove each comprising a chamber and an opening communicating with the chamber ; and a clamping hole , in communication with the opening and for insertion of a reaction tube ; at least one heat-conducting block , movably disposed in the chamber and having one end connected to an elastic element and another opposite end provided with an abutting portion , the elastic element enabling the abutting portion of the heat-conducting block to protrude from the opening and locate in the clamping hole ; and at least one accommodating groove each comprising a chamber and an opening communicating with the chamber ; and a clamping hole , in communication with the opening and for insertion of a reaction tube ; at least one heat-conducting block , movably disposed in the chamber and having one end connected to an elastic element and another opposite end provided with an abutting portion , the elastic element enabling the abutting portion of the heat-conducting block to protrude from the opening and locate in the clamping hole ; and a temperature control element, being connected to the heat-conducting body for heating and regulating a temperature of the heat-conducting block ; characterised in that the abutting portion of the heat-conducting block is spherical.
A metal surface treatment agent, comprising: a water-soluble or water-dispersible resin (A); a compound (B) comprising a nitrile group and an amino group; and at least one inorganic compound (C) selected from a chromium compound, a vanadium compound, a titanium compound and a zirconium compound; wherein a ratio [B M /A M ] between the mass (A M ) of the resin (A) and the mass (B M ) of the compound (B) is in a range of 0.03 to 1.50; wherein a ratio [B M /C M ] between the mass (B M ) of the compound (B) and the mass (C M ) of the inorganic compound (C) is in a range of 0.10 to 5.00; and wherein the titanium compound is at least one selected from the group consisting of titanyl sulfate, titanyl nitrate, titanium nitrate, titanyl chloride, titanium potassium oxalate, titanium lactate, titanium tetraisopropoxide, titanium acetylacetonate, diisopropyl titanium bis-acetylacetone, fluorotitanic acid and salts thereof, metatitanic acid obtained by thermal hydrolysis of an aqueous titanyl sulfate solution and salts thereof, and orthotitanic acid obtained by alkali neutralization of an aqueous titanyl sulfate solution and salts thereof. a water-soluble or water-dispersible resin (A); a compound (B) comprising a nitrile group and an amino group; and at least one inorganic compound (C) selected from a chromium compound, a vanadium compound, a titanium compound and a zirconium compound; wherein a ratio [B M /A M ] between the mass (A M ) of the resin (A) and the mass (B M ) of the compound (B) is in a range of 0.03 to 1.50; wherein a ratio [B M /C M ] between the mass (B M ) of the compound (B) and the mass (C M ) of the inorganic compound (C) is in a range of 0.10 to 5.00; and wherein the titanium compound is at least one selected from the group consisting of titanyl sulfate, titanyl nitrate, titanium nitrate, titanyl chloride, titanium potassium oxalate, titanium lactate, titanium tetraisopropoxide, titanium acetylacetonate, diisopropyl titanium bis-acetylacetone, fluorotitanic acid and salts thereof, metatitanic acid obtained by thermal hydrolysis of an aqueous titanyl sulfate solution and salts thereof, and orthotitanic acid obtained by alkali neutralization of an aqueous titanyl sulfate solution and salts thereof.
A vehicle lamp , comprising: a plurality of optical modules each emitting light and spaced apart from each other, wherein the plurality of optical modules includes at least one first optical module and at least one second optical module , and wherein a main lens of the first optical module and a main lens of the second optical module are formed of different types of lenses; and a mixing lens arranged in front of the plurality of optical modules and mixing the light emitted from each of the plurality of optical modules to form a light emitting image as a surface light source, wherein the mixing lens is curved backward from an in-board side along an out-board side, characterized in that the first optical module is arranged on the in-board side, and the second optical module is arranged on the out-board side, and the main lens of the first optical module is a concave lens, and the main lens of the second optical module is a convex lens. a plurality of optical modules each emitting light and spaced apart from each other, wherein the plurality of optical modules includes at least one first optical module and at least one second optical module , and wherein a main lens of the first optical module and a main lens of the second optical module are formed of different types of lenses; and a mixing lens arranged in front of the plurality of optical modules and mixing the light emitted from each of the plurality of optical modules to form a light emitting image as a surface light source, wherein the mixing lens is curved backward from an in-board side along an out-board side, characterized in that the first optical module is arranged on the in-board side, and the second optical module is arranged on the out-board side, and the main lens of the first optical module is a concave lens, and the main lens of the second optical module is a convex lens. the first optical module is arranged on the in-board side, and the second optical module is arranged on the out-board side, and the main lens of the first optical module is a concave lens, and the main lens of the second optical module is a convex lens.
Humanized antibody that specifically binds to IL-1R3 or a fragment or derivative thereof that contains at least a portion of said antibody that is sufficient to confer IL-1R3 binding specificity, wherein the antibody, antibody fragment or antibody derivative comprises three heavy chain CDRs and three light chain CDRs selected from the group consisting of CDR1H according to SEQ ID NO: 77, CDR2H according to SEQ ID NO: 94, CDR3H according to SEQ ID NO: 111, CDR1L according to SEQ ID NO: 128, CDR2L according to SEQ ID NO: 145, and CDR3L according to SEQ ID NO: 162, CDR1H according to SEQ ID NO: 79, CDR2H according to SEQ ID NO: 96, CDR3H according to SEQ ID NO: 113, CDR1L according to SEQ ID NO: 130, CDR2L according to SEQ ID NO: 147, and CDR3L according to SEQ ID NO: 175, and CDR1H according to SEQ ID NO: 81, CDR2H according to SEQ ID NO: 98, CDR3H according to SEQ ID NO: 115, CDR1L according to SEQ ID NO: 132, CDR2L according to SEQ ID NO: 149, and CDR3L according to SEQ ID NO: 166. CDR1H according to SEQ ID NO: 77, CDR2H according to SEQ ID NO: 94, CDR3H according to SEQ ID NO: 111, CDR1L according to SEQ ID NO: 128, CDR2L according to SEQ ID NO: 145, and CDR3L according to SEQ ID NO: 162, CDR1H according to SEQ ID NO: 79, CDR2H according to SEQ ID NO: 96, CDR3H according to SEQ ID NO: 113, CDR1L according to SEQ ID NO: 130, CDR2L according to SEQ ID NO: 147, and CDR3L according to SEQ ID NO: 175, and CDR1H according to SEQ ID NO: 81, CDR2H according to SEQ ID NO: 98, CDR3H according to SEQ ID NO: 115, CDR1L according to SEQ ID NO: 132, CDR2L according to SEQ ID NO: 149, and CDR3L according to SEQ ID NO: 166.
(3 S )-4-{4-[3-(3-methylpiperidin-1-yl)propoxy]phenyl}pyridine 1-oxide of formula (A): or its pharmaceutically acceptable salts and/or the solvates of said compound (A) or of its salts, for use for treating and/or preventing in a human patient disorders selected from Alzheimer's disease; attention; wakefulness and memorization disorders; cognitive deficits in psychiatric pathologies; cognitive, mood and vigilance disorders in particular in aged persons; depressive or asthenic states; Parkinson's disease; obstructive sleep apnea; dementia with Lewy bodies; vascular dementia; vertigo; motion sickness; obesity; diabetes and the metabolic syndrome; sleep disorders; stress; psychotropic disorders; epilepsy; depression; narcolepsy with or without cataplexy; disorders of the hypothalamohypophyseal secretion, the cerebral circulation and/or immune system; excessive daytime sleepiness, such as excessive daytime sleepiness and fatigue associated with Parkinson's disease, obstructive sleep apnea or dementia and/or for facilitating night works or adaptation to time shift in healthy humans; substance, notably alcohol abuse disorders; prevention of substance abuse withdrawal syndromes; attention deficit disorders; post-stroke fatigue, mood, cognitive and vigilance disorders; cognitive disorders in autism; chronic pain and chronic fatigue; attention and vigilance disorders of ADHD (attention-deficit hyperactivity disorder) in children or adults or following cerebrovascular accidents, where said use comprises the administration of compound (A) or its pharmaceutically acceptable salts, and/or the solvates of said salts or of said compound (A) in a human at a dose of base comprised between 10 and 90 μg a day (relative to compound (A) in the form of the base).
A method for transmitting data, comprising: sending , by user equipment, UE, a shortest hybrid automatic repeat request, HARQ, timing that can be processed by the UE to a base station, wherein a HARQ timing is a time for the base station to return an acknowledge/negative-acknowledge, ACK/NACK, after the UE sends data to the base station; receiving , by UE, multiple HARQ timings from the base station, wherein a shortest HARQ timing of the multiple HARQ timings is longer than the shortest HARQ timing that can be processed by the UE; sending , by the UE, multiple data packets to the base station, wherein each of the multiple data packets is corresponding to one of the multiple HARQ timings. sending , by user equipment, UE, a shortest hybrid automatic repeat request, HARQ, timing that can be processed by the UE to a base station, wherein a HARQ timing is a time for the base station to return an acknowledge/negative-acknowledge, ACK/NACK, after the UE sends data to the base station; receiving , by UE, multiple HARQ timings from the base station, wherein a shortest HARQ timing of the multiple HARQ timings is longer than the shortest HARQ timing that can be processed by the UE; sending , by the UE, multiple data packets to the base station, wherein each of the multiple data packets is corresponding to one of the multiple HARQ timings.